Loading...
XJPX3154
Market cap117mUSD
Jan 17, Last price  
826.00JPY
1D
-0.24%
1Q
-2.82%
Jan 2017
51.19%
IPO
501.95%
Name

Medius Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:3154 chart
P/E
16.33
P/S
0.07
EPS
50.58
Div Yield, %
2.63%
Shrs. gr., 5y
0.25%
Rev. gr., 5y
5.62%
Revenues
259.79b
+8.67%
58,599,294,000120,395,068,000132,833,577,000134,010,543,000145,969,388,000146,168,943,000158,400,395,000162,654,100,000168,135,875,000197,691,482,000210,388,116,000246,787,302,000221,694,333,000239,054,420,000259,789,000,000
Net income
1.12b
-24.92%
456,522,000245,358,000447,421,000896,227,000968,569,000433,295,000899,912,000863,221,000741,715,000-70,096,000951,357,0002,065,996,0001,867,916,0001,498,008,0001,124,676,000
CFO
1.92b
+56.92%
651,982,000-985,603,0003,889,918,000576,065,0003,045,200,000-962,560,0002,628,060,0002,447,772,000722,998,000-1,084,620,0001,169,117,0006,848,544,000-3,899,003,0001,224,486,0001,921,509,000
Dividend
Jun 27, 20250 JPY/sh

Profile

Medius Holdings Co., Ltd. operates in the medical care industry in Japan. The company sells medical equipment, such as syringes, gauze, other necessary medical consumables, and advanced medical system; and provides repair, after-sales, and maintenance services for medical equipment to hospitals and other medical facilities. It is also involved in the sale and rental of nursing care and welfare equipment to hospitals, nursing care facilities, and general individuals; and sale and rental of on-board medical instruments for ambulance, AEDs, and other emergency supplies and equipment with high social needs. The company was formerly known as Kyowa Medical Holdings, Inc. and changed its name to Medius Holdings Co., Ltd. in October 2010. Medius Holdings Co., Ltd. was founded in 2009 and is based in Tokyo, Japan.
IPO date
Jul 01, 2009
Employees
2,182
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
259,789,000
8.67%
239,054,420
7.83%
221,694,333
-10.17%
Cost of revenue
257,371,376
212,103,210
196,455,061
Unusual Expense (Income)
NOPBT
2,417,624
26,951,210
25,239,272
NOPBT Margin
0.93%
11.27%
11.38%
Operating Taxes
822,056
1,020,792
699,358
Tax Rate
34.00%
3.79%
2.77%
NOPAT
1,595,568
25,930,418
24,539,914
Net income
1,124,676
-24.92%
1,498,008
-19.80%
1,867,916
-9.59%
Dividends
(482,353)
(415,781)
(457,793)
Dividend yield
2.42%
2.16%
2.19%
Proceeds from repurchase of equity
7,221,487
BB yield
-34.47%
Debt
Debt current
19,969,000
14,972,395
12,335,047
Long-term debt
4,031,881
4,661,763
5,567,784
Deferred revenue
3,292,241
1,703,454
1,600,408
Other long-term liabilities
1,786,224
162,572
224,556
Net debt
5,607,858
3,037,493
3,455,517
Cash flow
Cash from operating activities
1,921,509
1,224,486
(3,899,003)
CAPEX
(2,211,772)
(923,832)
(4,589,053)
Cash from investing activities
(2,674,476)
(862,940)
(4,823,462)
Cash from financing activities
4,006,276
862,896
5,205,068
FCF
46,731,016
23,820,981
14,602,922
Balance
Cash
13,661,381
10,362,665
9,151,314
Long term investments
4,731,642
6,234,000
5,296,000
Excess cash
5,403,573
4,643,944
3,362,597
Stockholders' equity
16,894,068
15,901,510
14,637,205
Invested Capital
43,585,436
35,038,237
31,913,217
ROIC
4.06%
77.46%
89.39%
ROCE
4.79%
66.45%
69.93%
EV
Common stock shares outstanding
22,051
21,999
21,936
Price
905.00
3.43%
875.00
-8.38%
955.00
-5.82%
Market cap
19,956,511
3.68%
19,248,924
-8.11%
20,948,530
-5.85%
EV
25,564,369
22,286,417
24,404,047
EBITDA
4,234,489
28,621,998
26,405,379
EV/EBITDA
6.04
0.78
0.92
Interest
99,362
84,937
68,582
Interest/NOPBT
4.11%
0.32%
0.27%